TPST Award Disclosure
Frederick John W. · SEC Form 4 · Filed Nov 2, 2026
Award
Calculated transaction value
$0
Frederick John W. Director
TPST
Tempest Therapeutics
TPST
Transaction date
Oct 13, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 20 days later
TPST daily price context
Close on/before transaction
$0.68
Oct 13, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 25,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-114957
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tempest Therapeutics, Inc. TPST Current | Award | Oct 13, 2026 | $0 |